Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study

Neha K; Ravishankar V; Chethan Kumar G; Deepti V D

doi:10.5455/njppp.2023.13.10511202306112023

2024, Vol: 14, Issue: 5

14 / 5Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
15 / 11 / 2023

Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2496-2499

doi: 10.5455/njppp.2023.13.10511202306112023

Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study

Neha K, Ravishankar V, Chethan Kumar G, Deepti V D.

Abstract
Background: Rheumatoid arthritis (RA) is a joint disorder which affects the quality of life. Early diagnosis and symptomatic treatment can reduce the progression of disease. The treatment is associated with multiple drug therapy for long time. The use of multiple drugs can affect the patient’s economic status. The present study aimed to evaluate the cost-effectiveness of drugs used in the treatment of RA.

Aims and Objectives: The aim of the study was to evaluate the cost of mono and multiple drug therapy in the treatment of RA.

Materials and Methods: The study was conducted in the Department of Pharmacology and Orthopedic of Adichunchanagiri Institute of Medical Sciences, Karnataka for 6 months. A total of 50 patients were screened and 16 patients were included in the study. All the patients were explained study protocol and informed consent was obtained. Data related to age, gender, past history, and type of drug usage were recorded and analyzed. Microsoft Excel and SPSS (20.0) version were used for analysis.

Results: A total of 16 patients were analyzed in the study. The average cost-effective ratio was high for methotrexate and low is hydroxychloroquine. Comparison of cost-effectiveness between different drug combination therapies not showed any significant difference. Combination of non-steroidal anti-inflammatory drugs drug therapy has low cost compared to monoclonal antibody combination therapy.

Conclusion: Methotrexate and hydroxychloroquine combination therapy showed a high cost compared to monotherapy. Combination of low-price drugs can reduce the economic burden on patients.

Key words: Rheumatoid Arthritis; Methotrexate; Hydroxychloroquine; Average Cost Effective Ratio; Diseasemodifying Anti-rheumatoid Drugs; Non-steroidal Anti-inflammatory Drugs; Joint

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Neha K Articles by Ravishankar V Articles by Chethan Kumar G Articles by Deepti V D
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

K N, V R, G CK, D DV. Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Web Style

K N, V R, G CK, D DV. Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. https://www.njppp.com/?mno=174930 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.10511202306112023

AMA (American Medical Association) Style

K N, V R, G CK, D DV. Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Vancouver/ICMJE Style

K N, V R, G CK, D DV. Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. Natl J Physiol Pharm Pharmacol. (2023), [cited March 14, 2024]; 13(12): 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Harvard Style

K, N., V, . R., G, . C. K. & D, . D. V. (2023) Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. Natl J Physiol Pharm Pharmacol, 13 (12), 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Turabian Style

K, Neha, Ravishankar V, Chethan Kumar G, and Deepti V D. 2023. Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Chicago Style

K, Neha, Ravishankar V, Chethan Kumar G, and Deepti V D. "Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

MLA (The Modern Language Association) Style

K, Neha, Ravishankar V, Chethan Kumar G, and Deepti V D. "Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study." National Journal of Physiology, Pharmacy and Pharmacology 13.12 (2023), 2496-2499. Print. doi:10.5455/njppp.2023.13.10511202306112023

APA (American Psychological Association) Style

K, N., V, . R., G, . C. K. & D, . D. V. (2023) Evaluation of cost-effectiveness of various drugs used in the treatment of rheumatoid arthritis: An observational and prospective study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2496-2499. doi:10.5455/njppp.2023.13.10511202306112023

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272